John Paul II Medical Research Institute - iPS Cell Biobank

Back to FAQ Regarding COVID-19 Vaccines

Back to Coronavirus Research

Back to Coronavirus Research

Back to iPS Cell Biobank

Research

Research Overview

Institute Goals

Non-Profit Biotech Model

Gene Therapy vs. Cell Therapy

Specific Research Programs

iPS Cell Biobank

Secular Biotechnologies That Threaten Catholic Healthcare

Personalized Medicine in Oncology

C oronavirus Research

Research Milestones

iPS Cell Biobank

All iPS cell lines are reprogrammed with episomal vectors without c-Myc and Lin28 oncogenes to provide the most native disease-specific iPS cells free of viral and oncogenic influences.